Quarterly report pursuant to Section 13 or 15(d)

Patents (Details Narrative)

v3.10.0.1
Patents (Details Narrative) - USD ($)
6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Dec. 31, 2017
Common stock, par value $ 0.001   $ 0.001
Common stock, value $ 44,085   $ 40,895
Shares issued for purchase of patents 950,000    
Patent cost $ 572,023  
Spirulinex, LLC [Member]      
Shares issued for purchase of patents, shares 200,000    
Common stock price, per share $ 4.75    
Common stock, par value $ 0.001    
Common stock, value $ 950,000    
Shares issued for purchase of patents 350,000    
Patent cost $ 222,023